5F-AKB-48

5F-APINACA was first made in South Korea.It is expected to be a potent agonist of the CB1 receptor and CB2 receptor.Its metabolism has been described in literature.

Structurally 5F-APINACA closely resembles cannabinoid compounds from patent WO 2003/035005 but with a 5-fluoropentyl chain on the indazole 1-position, and 5F-AKB-48 falls within the claims of this patent, it is very similar to the corresponding pentanenitrile and 4-chlorobutyl compounds.